| abstract |
The present invention provides methods, uses and compositions for the treatment of cancer (e.g., lung cancer; cervical cancer; breast cancer; head and neck cancer; liver cancer; stomach cancer; bladder cancer; esophageal cancer; pancreatic cancer; kidney cancer; melanoma; ovarian cancer; or colorectal cancer). it's about More specifically, the present invention relates to the treatment of patients with cancer with anti-TIGIT antagonist antibodies, including treatment with anti-TIGIT antagonist antibodies in combination therapy. |